Finance

Beta
Lists
BNTC:NASDAQ
Benitec Biopharma Inc
$12.88
+4.72%
(+0.58) 1D
Jun 23, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNTC...
Open
$12.17
High
$13.23
Low
$11.68
Mkt. cap
442.48M
Avg. vol.
90.39K
Volume
97.82K
52-wk high
$16.76
52-wk low
$9.85
EPS
-$1.11
Beta
0.27
Shares outstanding
34.35M
No. of employees
19
Open
$12.17
High
$13.23
Low
$11.68
Mkt. cap
442.48M
Avg. vol.
90.39K
Volume
97.82K
52-wk high
$16.76
52-wk low
$9.85
EPS
-$1.11
Beta
0.27
Shares outstanding
34.35M
No. of employees
19
News stories
From sources across the web
About Benitec Biopharma Inc
CEO-
Employees19
Founded-
Headquarters-
SectorBiotechnology
Websitebenitec.com
Analyst Ratings
Based on 5 analysts giving stock ratings to BNTC in the past 3 months
Strong Buy
Buy
4
Hold
1
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BNTC in the last 3 months.
Highest
Current $12.88
$32.00 (+148.45%)
Average
$25.00 (+94.10%)
Lowest
$18.00 (+39.75%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Debjit Chattopadhyay
Guggenheim
Hold
Downgraded
-
-
06/10/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$32.00
+148.4%
05/26/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
$18.00
+39.8%
05/15/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
05/14/2026
Cory Kasimov
Evercore ISI
Buy
Initiated
$25.00
+94.1%
05/12/2026
Silvan Tuerkcan
Citizens JMP
Buy
Maintained
$22.00
+70.8%
11/04/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.70M
3.37M
5.83M
6.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.48M
6.43M
7.54M
7.28M
Operating expense
17.18M
9.80M
13.38M
13.58M
Total operating expenses
17.18M
9.80M
13.38M
13.58M
Operating income
-17.18M
-9.80M
-13.38M
-13.58M
Other non operating income
-126.00K
-84.00K
19.00K
-17.00K
EBT including unusual items
-16.15M
-8.96M
-11.84M
-11.94M
EBT excluding unusual items
-16.15M
-8.96M
-11.84M
-11.94M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.15M
-8.96M
-11.84M
-11.94M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.04M
1.01M
1.39M
1.59M
Interest expense
-
-
-
-
Net interest expenses
1.04M
1.01M
1.39M
1.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.16M
-9.79M
-13.36M
-13.57M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer